Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.

[1]  P. Moayyedi,et al.  Practice of gastroenterologists in treating flaring inflammatory bowel disease patients with clostridium difficile: Antibiotics alone or combined antibiotics/immunomodulators? , 2011, Inflammatory bowel diseases.

[2]  A. Ananthakrishnan,et al.  Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease , 2011, Inflammatory bowel diseases.

[3]  D. Rampton,et al.  Systematic review: Clostridium difficile and inflammatory bowel disease , 2011, Alimentary pharmacology & therapeutics.

[4]  D. Gerding,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults: 2010 Update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA) , 2010, Infection Control & Hospital Epidemiology.

[5]  O. Dekkers,et al.  European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). , 2009, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  R. P. Ross,et al.  The Vexed Relationship Between Clostridium Difficile and Inflammatory Bowel Disease: An Assessment of Carriage in an Outpatient Setting Among Patients in Remission , 2009, The American Journal of Gastroenterology.

[7]  P. Rutgeerts,et al.  Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. , 2009, Journal of Crohn's & colitis.

[8]  T. Concannon,et al.  Epidemiology of Clostridium difficile Colitis in Hospitalized Patients with Inflammatory Bowel Diseases , 2009, Diseases of the colon and rectum.

[9]  E. Dubberke,et al.  Review of Current Literature on the Economic Burden of Clostridium difficile Infection , 2009, Infection Control & Hospital Epidemiology.

[10]  G. Kaplan,et al.  A National Survey of the Prevalence and Impact of Clostridium difficile Infection Among Hospitalized Inflammatory Bowel Disease Patients , 2008, The American Journal of Gastroenterology.

[11]  A. Ananthakrishnan,et al.  Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease , 2007, Gut.

[12]  Dawn B. Beaulieu,et al.  Impact of Clostridium difficile on inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[13]  Kimberly A. Reske,et al.  Incidence of Clostridium difficile infection in inflammatory bowel disease. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[14]  M. Owings,et al.  Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–2003 , 2006, Emerging infectious diseases.

[15]  Simon Smale,et al.  Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[16]  A. Barkun,et al.  Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. , 2005, JAMA.

[17]  G. Thiéfin,et al.  Toxic effects of nonsteroidal antiinflammatory drugs on the small bowel, colon, and rectum. , 2005, Joint, bone, spine : revue du rhumatisme.

[18]  C. Viboud,et al.  Non-steroidal anti-inflammatory drugs as a risk factor for acute diarrhoea: a case crossover study , 2003, Gut.

[19]  J. Bartlett,et al.  A NTIBIOTIC -A SSOCIATED D IARRHEA , 2002 .

[20]  F. Barbut,et al.  Epidemiology of Clostridium difficile-associated infections. , 2001, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  S. Hanauer,et al.  Management of Crohn's Disease in Adults , 2001, The American Journal of Gastroenterology.

[22]  L. Fried,et al.  Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  L. Kitchen,et al.  Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease , 2000, American Journal of Gastroenterology.

[24]  B. Korelitz,et al.  Effects of nonsteroidal antiinflammatory drugs on inflammatory bowel disease: a case-control study , 2000, American Journal of Gastroenterology.

[25]  D. Gerding,et al.  Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  J. Evans,et al.  Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease. , 1997, Gut.

[27]  L. Peterson,et al.  Clostridium Difficile-Associated Diarrhea and Colitis , 1995, Infection Control & Hospital Epidemiology.

[28]  S. Hanauer,et al.  Cyclosporine in severe ulcerative colitis refractory to steroid therapy. , 1994, The New England journal of medicine.

[29]  J. Vane,et al.  Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  E. Whitacre,et al.  Colitis induced by nonsteroidal anti-inflammatory drugs. Report of four cases and review of the literature. , 1992, Archives of internal medicine.

[31]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[32]  H. Kaufmann,et al.  Nonsteroidal anti-inflammatory drugs activate quiescent inflammatory bowel disease. , 1987, Annals of internal medicine.

[33]  R. F. Harvey,et al.  A SIMPLE INDEX OF CROHN'S-DISEASE ACTIVITY , 1980, The Lancet.

[34]  A. Ananthakrishnan.  Clostridium difficile infection: epidemiology, risk factors and management , 2011, Nature Reviews Gastroenterology &Hepatology.

[35]  R. Perrin,et al.  Report of four cases and review of the literature , 2006 .

[36]  A. R. Tanner,et al.  Colonic inflammation and nonsteroidal anti-inflammatory drug administration. An assessment of the frequency of the problem. , 1988, Digestion.